Topic: How To Invest

What is Pat’s commentary for the week of January 28, 2020

Article Excerpt

Pfizer’s reorganization paves your way to blockbuster-drug gains Drug stocks hold special appeal for investors: Many assume that as the baby-boom generation moves into retirement, demand for pharmaceuticals will skyrocket. That’s undoubtedly true. However, as we’ve often pointed out, this high potential can lead investors to underestimate the risks in drug stocks. Drug companies often invest tens if not hundreds of millions of dollars to create, test and secure regulatory approval for a single new drug. Even when regulators grant approval for a new drug, the company may be unable to recover its investment before its patent on the drug expires or a better drug hits the market. That’s why investors need to be highly selective in choosing their drug stocks. It’s also why Pfizer is the only drug stock we recommend to our clients as a buy. We’ve done so since 2011 and the stock has rewarded our investors with a solid 94% gain, along with a near doubling in Pfizer’s…